Methotrexate-induced Hyponatremia in Rheumatoid Arthritis: A Case Report

Abstract

Methotrexate is a widely used medication with immunosuppressive and immunomodulatory effects on cancers and autoimmune diseases, it is known that hyponatremia may be a side effect of its use in high doses when treating cancers, but it is unknown in low doses when used as an immunomodulator. Hyponatremia may be asymptomatic initially but can progress to fatal consequences if left untreated. Here we present a case of hyponatremia secondary to a low dose of methotrexate in an elderly patient with rheumatoid arthritis.

References

1. 1.Koumpis E, Florentin M, Hatzimichael E, Liamis G. Hyponatremia in patients with hematologic diseases. Journal of Clinical Medicine. 2020;9(11):3721.
2. 2.Diskin C, Dansby LM, Radcliff L, Carter TB, Graves E, Graves A. Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: Is a natriuretic peptide activated? The American Journal of the Medical Sciences. 2006;331(1):37–9.
3. 3.Monga D. Methotrexateinduced hyponatremia in leptomeningeal carcinomatosis - SHM abstracts: Society of Hospital Medicine [Internet]. SHM Abstracts | Society of Hospital Medicine. 2022 [cited 2023Apr18]. Available from: https://shmabstracts.org/ abstract/methotrexate-induced-hyponatremia-in-leptomeningeal-carcinoma- Majmaah Journal of Health Sciences ,Vol. 11, Issue 3, July - 2023, DhuAl-Hijjah - 1444 113 Methotrexate-induced Hyponatremia in RheumatoidArthritis –ACase Report tosis/
4. 4.Frahm H, von Hülst M. Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy. Z Gesamte Inn Med. 1988;43(15):411–4.
5. 5.Liamis G, Filippatos TD, Elisaf MS. Electrolyte disorders associated with the use of anticancer drugs. European Journal of Pharmacology. 2016;777:78–87.
6. 6.Severin MJ, Torres AM. Time course effects of methotrexate on renal handling of water and electrolytes in rats. role of aquaporin-2 and Na-K-2Clcotransporter. Toxicology Letters. 2019;311:27–36.
7. 7.Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A. Medication-induced SIADH: Distribution and characterization according to medication class. British Journal of Clinical Pharmacology. 2017;83(8):1801–7.
8. 8.Pressler CA, Heinzinger J, Jeck N, Waldegger P, Pechmann U, Reinalter S, et al. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal na+-k+-2cl− co-transporter. Journal of the American Society of Nephrology. 2006;17(8):2136–42.